The role of GCN2 in human induced pluripotent stem cell maintenance, differentiation and endothelial cell function
- Institution
- UNIVERSITY OF ILLINOIS AT CHICAGO, IL
- Principal investigator
- Phoenix Toboz
- Funding
- $46K
- Duration
- 2024–2026
Moonbase score
Still being scored
Abstract
PROJECT SUMMARY The serine/threonine protein kinase GCN2 (General control nonderepressible 2) is an amino acid sensor that coordinates mRNA translation (also known as protein synthesis) in response to amino acid availability through phosphorylation of eIF2. Despite extensive studies of the GCN2-eIF2 pathway in the context of cellular stress, the importance of this pathway in early embryogenesis and differentiation has not been established. The focus of this research is to uncover the role of GCN2-dependent translational control in mediating the effect of amino acid deprivation stress on human induced pluripotent stem cells (hiPSCs), hiPSC to endothelial cell (EC) differentiation and hiPSC-EC function. Our preliminary data show that the expression of several key pluripotent factors is reduced in CRISPR-engineered GCN2 knock out (GCN2 KO) hiPSCs compared to isogenic control hiPSCs. We also observed that hiPSCs undergo a profound increase in p-eIF2 at an early stage of differentiation toward endothelial cells. Additionally, two downstream targets of p-eIF2, ATF4 and GADD34, were induced on day 3 of differentiation. Given these findings, I hypothesize that GCN2 regulates hiPSCs, hiPSC to EC differentiation and hiPSC-EC function through phosphorylation of eIF2. The proposed experiments will fully assess the self-renewal and EC differentiation potential of GCN2 KO hiPSCs using cellular and biochemical strategies. Importantly, ribosome footprinting, a high-throughput translatome technique, will be used to identify downstream translational targets of the GCN2-eIF2α pathway that regulate hiPSC-EC function in response to amino acid stress. The identified GCN2 targets will be functionally assessed for their role in endothelial cell differentiation and function. The results of this research will provide insight into new candidates for treating endothelial-related diseases.
LOADING MOONBASE SCORE
Questions for UNIVERSITY OF ILLINOIS AT CHICAGO
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same institution, same topic, scored first.
- NIH · University of Illinois at Chicago47
MASLD protection by STAT5-regulated transcription factors
Rhonda D Kineman · $825K · 2025–2030
- NIH · University of Illinois at Chicago47
Identifying a novel pathway that regulates RA immunometabolism
Shiva Shahrara · $715K · 2022–2028
- NIH · University of Illinois at Chicago45
Precise Combination Strategies Targeting Carbapenem-Resistant Klebsiella pneumoniae
Zackery P. Bulman · $720K · 2022–2027